The newly developed multi-functional, thermodynamically and chemically stable RNA nanoparticles were designed to harbor cancer targeting ligands as well as delta-5-desaturase-targeted siRNA to inhibit delta-5-desaturase expression specifically in tumor cells. The gene discussed is FADS1; the disease is neoplasm.